Frontlight ResearchEarly access
Follicular lymphoma trials in Israel
6 of 8 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleA Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
- Where
- Haifa, Jerusalem, Ramat Gan, Tel Aviv
- Age
- 18 years and over
- People
- 280 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07519772 · EU 2025-523005-15-00 - Phase 2/3Taking peopleA Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
- Where
- Jerusalem, Ramat Gan, Tel Aviv
- Age
- 18 years and over
- People
- 960 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07634471 · EU 2025-522777-10-00 - Phase 3Taking peopleA Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
- Where
- Ashdod, Haifa, Jerusalem, Nahariya, Petah Tikva, Ramat Gan, Tel Aviv
- Age
- 18 years and over
- People
- 822 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06091254 · EU 2022-502660-20-00 - Phase 3Taking peopleA Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
- Where
- Ashdod, Jerusalem, Nahariya, Petah Tikva, Ramat Gan, Tel Aviv
- Age
- 18 years and over
- People
- 580 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06149286 · EU 2022-503092-28-00 - Phase 1/2Taking peopleDose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma
- Where
- Haifa, Jerusalem, Petah Tikva, Tel Aviv
- Age
- 18 years and over
- People
- 180 worldwide
- Run by
- ModeX Therapeutics, An OPKO Health Company
See details and how to joinNCT07249905 - Phase 2Taking peopleTrial to Evaluate Efficacy and Safety of Subcutaneous Mosunetuzumab in Previously Untreated Low Tumor Burden Follicular Lymphoma .
- Where
- Haifa, Jerusalem, Tel Aviv
- Age
- 18 years and over
- People
- 40
- Run by
- Tel-Aviv Sourasky Medical Center
See details and how to joinNCT07191249